159 results  1 of 8 

1 GBA inhibition suppresses ovarian cancer growth, survival and receptor tyrosine kinase AXL-mediated signaling pathways
Gang Wang, Baisha Ouyang, Fang Jing, Xiaoyan Dai
Korean J Physiol Pharmacol.2023;27(1):21-29.   Published online 2023 January 1     DOI: http://dx.doi.org/10.4196/kjpp.2023.27.1.21
      
2 Cisplatin-Induced Ototoxicity: Updates on Potential Molecular Mechanism
Da Jung Jung
Korean J Otorhinolaryngol-Head Neck Surg.2022;65(10):569-579.   Published online 2022 October 17     DOI: http://dx.doi.org/10.3342/kjorl-hns.2022.00507
      
3 Effect of prehydration solution on hearing threshold after chemotherapy in patients with head and neck cancers: a retrospective study
Dongbin Ahn, Kyu-Yup Lee, Eunjung Oh, Minji Oh, Boseung Jung, Da Jung Jung
J Yeungnam Med Sci.2022;40(2):164-171.   Published online 2022 August 24     DOI: http://dx.doi.org/10.12701/jyms.2022.00276
      
4 Effects of exercise on AKT/PGC1-α/FOXO3a pathway and muscle atrophy in cisplatin-administered rat skeletal muscle
Jun Hyun Bae, #, Dae Yun Seo, #, Sang Ho Lee, Chaeyoung Shin, Parivash Jamrasi, Jin Han, Wook Song
Korean J Physiol Pharmacol.2021;25(6):585-592.   Published online 2021 November 1     DOI: http://dx.doi.org/10.4196/kjpp.2021.25.6.585
      
5 A Single-Arm, Prospective, Phase II Study of Cisplatin Plus Weekly Docetaxel as First-Line Therapy in Patients with Metastatic or Recurrent Salivary Gland Cancer
Hye Ryeon Kim, Su Jin Lee, Sehhoon Park, Hyun Ae Jung, Se-Hoon Lee, Han-Sin Jeong, Man Ki Chung, Myung-Ju Ahn
Cancer Res Treat.2022;54(3):719-727.   Published online 2021 November 1     DOI: http://dx.doi.org/10.4143/crt.2021.1019
      
6 Clinical Characteristics, Treatment Delivery, and Cisplatin Eligibility in Korean Patients Initially Diagnosed with Urothelial Carcinoma
Kwonoh Park, Jong Kil Nam, Bon Jin Koo, Hyun Jung Lee, Tae Un Kim, Hwaseong Ryu, Yun Jeong Hong, Seungsoo Lee, Dong Hoon Lee, Sung Woo Park
Ewha Med J.2021;44(3):63-69.   Published online 2021 July 31     DOI: http://dx.doi.org/10.12771/emj.2021.44.3.63
      
7 Prostaglandin D2 contributes to cisplatin-induced neuropathic pain in rats via DP2 receptor in the spinal cord
Yaqun Li, Woong Mo Kim, Seung Hoon Kim, Hyun Eung You, Dong Ho Kang, Hyung Gon Lee, Jeong Il Choi, Myung Ha Yoon
Korean J Pain.2021;34(1):27-34.   Published online 2021 January 1     DOI: http://dx.doi.org/10.3344/kjp.2021.34.1.27
      
8 Phase II Trial of Postoperative Adjuvant Gemcitabine and Cisplatin Chemotherapy Followed by Chemoradiotherapy with Gemcitabine in Patients with Resected Pancreatic Cancer
Kyung-Hun Lee, Eui Kyu Chie, Seock-Ah Im, Jee Hyun Kim, Jihyun Kwon, Sae-Won Han, Do-Youn Oh, Jin-Young Jang, Jae-Sung Kim, Tae-You Kim, Yung-Jue Bang, Sun Whe Kim, Sung W. Ha
Cancer Res Treat.2021;53(4):1096-1103.   Published online 2020 December 30     DOI: http://dx.doi.org/10.4143/crt.2020.928
      
9 Antinociceptive role of neurotensin receptor 1 in rats with chemotherapy-induced peripheral neuropathy
Mei Yin, Yeo-Ok Kim, Jeong-Il Choi, Seongtae Jeong, Si-Ho Yang, Hong-Beom Bae, Myung-Ha Yoon
Korean J Pain.2020;33(4):318-325.   Published online 2020 October 1     DOI: http://dx.doi.org/10.3344/kjp.2020.33.4.318
      
10 Impressive effect of cisplatin monotherapy on a patient with heavily pretreated triple-negative breast cancer with poor performance
Dong Won Baek, Ji-Young Park, Soo Jung Lee, Yee Soo Chae
Yeungnam Univ J Med.2020;37(3):230-235.   Published online 2020 January 22     DOI: http://dx.doi.org/10.12701/yujm.2019.00423
      
11 p90RSK Activation Promotes Epithelial-Mesenchymal Transition in Cisplatin-Treated Triple-Negative Breast Cancer Cells
Yujin Jin, Kyung-Sun Heo
J Bacteriol Virol.2019;49(4):221-229.   Published online 2019 December 31     DOI: http://dx.doi.org/10.4167/jbv.2019.49.4.221
      
12 Effects of genistein on anti-tumor activity of cisplatin in human cervical cancer cell lines
Hyunju Liu, Garam Lee, Jung In Lee, Tae-Gyu Ahn, Soo Ah Kim
Obstet Gynecol Sci.2019;62(5):322-328.   Published online 2019 August 6     DOI: http://dx.doi.org/10.5468/ogs.2019.62.5.322
      
13 Effect of quercetin on the anti-tumor activity of cisplatin in EMT6 breast tumor-bearing mice
Hyunju Liu, Jung In Lee, Tae-Gyu Ahn
Obstet Gynecol Sci.2019;62(4):242-248.   Published online 2019 June 19     DOI: http://dx.doi.org/10.5468/ogs.2019.62.4.242
      
14 Impact of BRCA1/2 gene mutations on survival of patients with pancreatic cancer: A case-series analysis
Ernesto Barzola Navarro, Emilio Vicente López, Yolanda Quijano, Riccardo Caruso, Valentina Ferri, Hipolito Durand, Isabel Fabra Cabrera, Eduardo Diaz Reques, Benedetto Ielpo, Anastasiia Yuriyivna Glagolieva, Carlos Plaza
Ann Hepatobiliary Pancreat Surg.2019;23(2):200-205.   Published online 2019 May 31     DOI: http://dx.doi.org/10.14701/ahbps.2019.23.2.200
      
15 Combination Chemotherapy with High Dose Cisplatin - Cyclophosphamide in Primary Epithelial Ovarian Cancer
Jeong Sup Yun, Ha Jeong Kim, Sung Kyoo Jang, Ki Hyung Kim, Man Soo Yoon
Korean J Gynecol Oncol Colposc.2001;12(1):12-22.   Published online 2019 March 13     DOI: http://dx.doi.org/10.3802/kjgoc.2001.12.1.12
      
16 A Comparative Study of the Toxicity Between carboplatin and Cisplatin in VBP Combination Chemotherapy
Pan Young Kim, Hee Sung Seo, Jung Ok Shin, Kyung Taeck Jang, Dong Han Bae
Korean J Gynecol Oncol Colposc.1996;7(3):189-198.   Published online 2019 March 13     DOI: http://dx.doi.org/10.3802/kjgoc.1996.7.3.189
      
17 Clinical Efficacy of Ifosfamide-Based Regimen in Refractory of Relapsed Ovarian Cancer
Hyo Pyo Lee, Noh Hyun Park, Jae Weon Kim, Seo Young Park, Yong Sang Song, Soon Beom Kang
Korean J Gynecol Oncol Colposc.1996;7(4):263-269.   Published online 2019 March 13     DOI: http://dx.doi.org/10.3802/kjgoc.1996.7.4.263
      
18 Effects of cell growth inhibition on the combination of cisplatin with green tea extracts
Hyun Kyung Kim, Young Haw Kang, Sun Young Kwak, Guo Hua Ding, Su Mi Bae, Eun Kyung Park, Yong Seok Lee, Jung Kim, Yong Wook Kim, Duck Yeong Ro, Joon Mo Lee, Sung Eun Namkoong, Hong Seok Chang, Heung Jae Chun, Dae Seog Lim, Woong Shick Ahn
Korean J Gynecol Oncol.2005;16(4):347-353.   Published online 2019 March 12     DOI: http://dx.doi.org/10.3802/kjgo.2005.16.4.347
      
19 Neoadjuvant chemotherapy with mitomycin-C, vincristine and cisplatin (MVC) for patients with loco-regionally advanced cervical carcinoma
Chel Hun Choi, Tae Joong Kim, Jeong Won Lee, Byoung Gie Kim, Je Ho Lee, Duk Soo Bae
Korean J Gynecol Oncol.2006;17(1):15-21.   Published online 2019 March 12     DOI: http://dx.doi.org/10.3802/kjgo.2006.17.1.15
      
20 Concurrent Cisplatin and 5-Flurouracil Chemotherapy and Radiation Therapy for Locally Advanced Cancer of The Uterine Cervix
Hwi Gon Kim, Kwang Hyun Lee, Ji Hyun Kim, Hyoung Sik Lee, Moon Seok Cha, Hyun Ho Kim
Korean J Gynecol Oncol Colposc.2003;14(1):13-20.   Published online 2019 March 12     DOI: http://dx.doi.org/10.3802/kjgoc.2003.14.1.13
      

 1 of 8